Nereid Therapeutics says its drug discovery platform is based on proprietary technologies aimed at precisely measuring, interrogating, and controlling phase separation in mammalian cells . . .
The post Set Phase Separation to Stun appeared first on GEN – Genetic Engineering and Biotechnology News.
